Ghia Jean-Eric, Blennerhassett Patricia, El-Sharkawy Rami T, Collins Stephen M
Intestinal Diseases Research Programme, Health Science Center, McMaster Univ. Medical Center, 1200 Main St. West, Hamilton, ON L8N 3Z5, Canada.
Am J Physiol Gastrointest Liver Physiol. 2007 Oct;293(4):G711-8. doi: 10.1152/ajpgi.00240.2007. Epub 2007 Aug 2.
The vagus nerve inhibits the response to systemic administration of endotoxin, and we have recently extended this observation to show that the vagus attenuates acute experimental colitis in mice. The purpose of the present study was to determine whether there is a tonic counterinflammatory influence of the vagus on colitis maintained over several weeks. We assessed disease activity index, macroscopic and histological damage, myeloperoxidase (MPO) activity, and Th1 and Th2 cytokine profiles in chronic colitis induced by administration of dextran sodium sulfate (DSS) in drinking water for three cycles during 5 days with 11 days of rest between each cycle (DSS 3, 2, 2%) in healthy and vagotomized C57BL/6 mice and in mice deficient in macrophage-colony stimulating factor (M-CSF). A pyloroplasty was performed in vagotomized mice. Vagotomy accelerated the onset and the severity of inflammation during the first and second but not the third cycle. Although macroscopic scores were not significantly changed, histological scores as well as MPO activity and colonic tissue levels of IL-1alpha, TNF-alpha, IFN-gamma, and IL-18 but not IL-4 were significantly increased in vagotomized mice compared with sham-operated mice that received DSS. In control mice (without colitis), vagotomy per se did not affect any inflammatory marker. Vagotomy had no effect on the colitis in M-CSF-derived macrophage-deficient mice. These results indicate that the vagus protects against acute relapses on a background of chronic inflammation. Identification of the molecular mechanisms underlying the protective role of parasympathetic nerves opens a new therapeutic avenue for the treatment of acute relapses of chronic inflammatory bowel disease.
迷走神经可抑制对内毒素全身给药的反应,我们最近扩展了这一观察结果,表明迷走神经可减轻小鼠的急性实验性结肠炎。本研究的目的是确定迷走神经对持续数周的结肠炎是否具有持续性的抗炎影响。我们评估了疾病活动指数、宏观和组织学损伤、髓过氧化物酶(MPO)活性以及Th1和Th2细胞因子谱,这些指标来自于健康和迷走神经切断的C57BL/6小鼠以及巨噬细胞集落刺激因子(M-CSF)缺陷小鼠,它们通过在饮用水中给予葡聚糖硫酸钠(DSS)诱导慢性结肠炎,共进行三个周期,每个周期5天,每个周期之间休息11天(DSS浓度为3%、2%、2%)。对迷走神经切断的小鼠进行了幽门成形术。迷走神经切断术加速了第一和第二个周期(而非第三个周期)炎症的发作和严重程度。尽管宏观评分没有显著变化,但与接受DSS的假手术小鼠相比,迷走神经切断的小鼠组织学评分以及MPO活性和结肠组织中IL-1α、TNF-α、IFN-γ和IL-18(而非IL-4)的水平显著升高。在对照小鼠(无结肠炎)中,迷走神经切断术本身不影响任何炎症标志物。迷走神经切断术对M-CSF衍生的巨噬细胞缺陷小鼠的结肠炎没有影响。这些结果表明,迷走神经可在慢性炎症背景下预防急性复发。确定副交感神经保护作用的分子机制为治疗慢性炎症性肠病的急性复发开辟了一条新的治疗途径。